A number of studies have implicated cathepsin K expression in cancer progression and metastasis using cathepsin K inhibitors [19,20], mRNA analysis [21,22], and immunohistochemical labeling of normal and tumor sections [21-23], but the specific identification and quantification of the mature, active cathepsin K in these tumors has not been shown. Here, CTSK is linked to neoplasm.